All In Biotech

Drug Trial Radar · NCT06316297

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Apr 5, 2024

Primary completion

Nov 30, 2028

Study completion Nov 30, 2028

Sponsor

Lead sponsor
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
Mar 18, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to four dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a Core Study followed by an optional Long-Term Extension (LTE). The Core Study will consist of: * Two cohorts evaluating the 2-administration regimen (Cohorts A): Sentinel Cohort A and Main Cohort A. * Two cohorts evaluating the 3-administration regimen (Cohorts B): Sentinel Cohort B and Main Cohort B. Participants from Sentinel Cohorts A and B and from Main Cohort A will be invited to an additional 30-month follow up after completing their last planned Core Study visit to assess the long-term effects of the vaccine. Participants from Main Cohort B will be invited to another LTE study managed through a separate protocol.

Conditions

  • Acne

Interventions

  • Acne mRNA vaccineBiological

    Pharmaceutical form: Liquid suspension for injection Route of administration: intramuscular

  • PlaceboOther

    Pharmaceutical form: Liquid solution for injection Route of administration: intramuscular

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Core Study - Sentinel Cohorts A and B: Number of participants with unsolicited systemic AEsTime frame: 30 minutes after each administration
  2. Core Study - Sentinel Cohorts A and B: Number of participants with solicited injection site and systemic reactionsTime frame: Up to 7 days after each administration
  3. Core Study - Sentinel Cohorts A and B: Number of participants with unsolicited AEsTime frame: Up to 28 days after each administration
  4. Core Study - Sentinel Cohorts A and B: Number of participants with MAAEsTime frame: Up to 6 months after each administration
  5. Core Study - Sentinel Cohorts A and B: Number of participants with SAEsTime frame: Up to 6 months after each administration
  6. Core Study - Sentinel Cohorts A and B: Number of participants with AESIsTime frame: Up to 6 months after each administration
  7. Core Study - Sentinel Cohorts A and B: Number of participants with out-of-range biological test results (including shift from baseline values)Time frame: Through 7 days after administration (Day 8)
  8. Core Study - Main Cohort A: Percentage change from baseline (Day 1) in the number of inflammatory acne lesions on faceTime frame: At 2 months post last administration
  9. Core Study - Main Cohort A: Percentage change from baseline (Day 1) in the number of non-inflammatory acne lesions on faceTime frame: At 2 months post last administration
  10. Core Study - Main Cohort B: Percentage change from baseline (Day 1) in the total number of acne lesions on face atTime frame: At 2 months post last administration
  11. Long-Term Extension - Sentinel Cohorts A, B and Main Cohort: Number of participants with SAEs and AESIsTime frame: Up to 38 or 40 months after first administration

Locations

94 sites in 4 countries. Site status is shown where the registry gives one.

  • Center for Dermatology and Plastic Surgery- Site Number : 8400111

    Scottsdale, Arizona · Recruiting

  • Private Practice - Dr. Francisco Badar- Site Number : 8400067

    Cerritos, California · Recruiting

  • Encino Research Center- Site Number : 8400033

    Encino, California · Recruiting

  • Paradigm Clinical Research Centers- Site Number : 8400064

    La Mesa, California · Recruiting

  • Sunwise Clinical Research- Site Number : 8400108

    Lafayette, California · Recruiting

  • Chemidox Clinical Trials- Site Number : 8400075

    Lancaster, California · Recruiting

  • Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400058

    Los Angeles, California · Recruiting

  • LA Universal Research Center- Site Number : 8400059

    Los Angeles, California · Recruiting

  • Alliance Clinical - West Hills- Site Number : 8400131

    Los Angeles, California · Recruiting

  • Carbon Health - North Hollywood - NoHo West- Site Number : 8400076

    North Hollywood, California · Recruiting

  • Northridge Clinical Trials - Northridge- Site Number : 8400053

    Northridge, California · Recruiting

  • Profound Research - Dermatologist Medical Group of North County- Site Number : 8400099

    Oceanside, California · Recruiting

  • Cura Clinical Research - Oxnard- Site Number : 8400062

    Oxnard, California · Recruiting

  • Amicis Research Center, LLC- Site Number : 8400110

    Palmdale, California · Recruiting

  • Empire Clinical Research - Pomona- Site Number : 8400055

    Pomona, California · Recruiting

  • Peninsula Research Associates- Site Number : 8400102

    Rolling Hills Estates, California · Recruiting

  • Artemis Institute for Clinical Research - San Diego - Washington Street- Site Number : 8400103

    San Diego, California · Recruiting

  • California Research Foundation- Site Number : 8400095

    San Diego, California · Recruiting

  • NorthBay Clinical Research- Site Number : 8400066

    Santa Rosa, California · Recruiting

  • Encore Medical Research of Boynton Beach- Site Number : 8400116

    Boynton Beach, Florida · Recruiting

  • Driven Research- Site Number : 8400135

    Coral Gables, Florida · Recruiting

  • HealthMed Clinical Center- Site Number : 8400071

    Coral Gables, Florida · Recruiting

  • Universal Medical Research - Coral Gables- Site Number : 8400081

    Coral Gables, Florida · Recruiting

  • Genomics Medical Research- Site Number : 8400120

    Cutler Bay, Florida · Recruiting

  • Direct Helpers Research Center- Site Number : 8400118

    Hialeah, Florida · Recruiting

  • Zenith Clinical Research- Site Number : 8400127

    Hollywood, Florida · Recruiting

  • Encore Medical Research - Hollywood- Site Number : 8400122

    Hollywood, Florida · Recruiting

  • Universal Medical and Research Center- Site Number : 8400079

    Homestead, Florida · Recruiting

  • Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006

    Jacksonville, Florida · Recruiting

  • K2 Medical Research - The Villages - Northeast 138th Lane- Site Number : 8400063

    Lady Lake, Florida · Recruiting

  • Dr. Manuel J Hernandez Clinical Research and Associates, Inc.- Site Number : 8400106

    Miami, Florida · Recruiting

  • SouthCoast Research Center- Site Number : 8400114

    Miami, Florida · Recruiting

  • Advanced Medical Research Institute - Miami- Site Number : 8400100

    Miami, Florida · Recruiting

  • Health and Life Research Institute- Site Number : 8400070

    Miami, Florida · Recruiting

  • WellQuest Clinical- Site Number : 8400082

    Miami, Florida · Recruiting

  • Renstar Medical Research - Ocala - Northeast 1st Avenue- Site Number : 8400021

    Ocala, Florida · Recruiting

  • Leading Edge Dermatology- Site Number : 8400077

    Plantation, Florida · Recruiting

  • Nuline Clinical Trial Center- Site Number : 8400060

    Pompano Beach, Florida · Recruiting

  • D&H Tamarac Research Center- Site Number : 8400121

    Tamarac, Florida · Recruiting

  • TrueBlue Clinical Research- Site Number : 8400016

    Tampa, Florida · Recruiting

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.